Search

Search Constraints

You searched for: Author/Creator Cetnar, Jeremy

Search Results

1. A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer. Issue 20 (5th August 2020)

2. Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial. Issue 2 (February 2016)